Press release
Radiofrequency Ablation Devices Market to Reach US$ 13.54 Billion by 2033 at 10.7% CAGR; North America Leads with 38% Share
Radiofrequency Ablation Devices Market
Radiofrequency ablation devices are used to treat tumors, cardiac arrhythmias, and chronic pain by delivering controlled thermal energy to targeted tissues. Growing adoption across oncology, cardiology, and pain management applications, along with shorter recovery times and reduced hospital stays, is accelerating market demand. Continuous technological innovations and expanding clinical indications are further supporting global market expansion.
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/radiofrequency-ablation-devices-market?sai-v
The Radiofrequency Ablation Devices Market refers to the global industry focused on the development, manufacturing, and use of medical devices that employ radiofrequency energy to destroy or modify abnormal tissue for therapeutic purposes.
Key Developments
✅ January 2026: In North America, adoption of next-generation RFA devices with enhanced temperature control, real-time feedback, and integrated imaging guidance increased across cardiac, pain management, and tumor ablation procedures, improving precision and clinical outcomes.
✅ December 2025: In Europe, healthcare providers expanded use of minimally invasive RFA technologies in chronic pain and oncology specialties, supported by updated clinical guidelines emphasizing reduced recovery times and improved patient comfort.
✅ November 2025: In Asia-Pacific, rising investments in advanced interventional radiology infrastructure and training programs bolstered demand for RFA systems in liver, kidney, and lung cancer treatments.
✅ October 2025: In Latin America, increased awareness and availability of RFA for varicose veins and musculoskeletal pain management contributed to broader procedural adoption in key urban healthcare facilities.
✅ September 2025: In the Middle East, hospitals and specialty clinics integrated next-gen RFA tools with robotics-assisted guidance and enhanced safety features to support complex ablation procedures.
✅ August 2025: In Africa, early adoption of portable and cost-effective RFA solutions helped expand minimally invasive treatment options in regional surgical centers and tertiary hospitals.
Mergers & Acquisitions
✅ January 2026: In North America, a leading medical device manufacturer acquired a specialist radiofrequency ablation technology company to strengthen its interventional oncology and pain management device portfolio.
✅ December 2025: In Europe, a major healthcare equipment group acquired an advanced RFA systems provider to expand offerings in minimally invasive therapeutic solutions across clinical disciplines.
✅ November 2025: In Asia-Pacific, a regional medtech investor acquired a local RFA device developer to broaden market reach and support manufacturing of next-generation ablation systems.
Key Players
Boston Scientific Corporation | Medtronic | Stryker | Abbott | Smith+Nephew | Johnson & Johnson Services, Inc. | AngioDynamics | Hologic, Inc. | Arthrex, Inc. | STARmed America
Emerging Players
Ananya Health | Sedivention | Field Medical
Key Highlights
Boston Scientific Corporation holds 21.8% share, driven by its strong portfolio of radiofrequency ablation systems, leadership in cardiovascular and oncology applications, and global hospital adoption.
Medtronic holds 18.6% share, supported by advanced minimally invasive ablation technologies and broad presence across cardiac and pain management procedures.
Abbott holds 14.2% share, benefiting from electrophysiology-focused RFA devices and strong penetration in cardiac rhythm management.
Johnson & Johnson Services, Inc. holds 12.5% share, driven by its surgical technologies division and integration of RFA devices in minimally invasive procedures.
Stryker holds 10.4% share, supported by orthopedic and sports medicine ablation systems and strong surgeon preference.
Smith+Nephew holds 8.7% share, leveraging RFA devices in arthroscopy, pain management, and soft tissue procedures.
AngioDynamics holds 6.3% share, focused on RFA solutions for vascular and oncology indications.
Hologic, Inc. holds 4.2% share, driven by women's health-focused ablation devices and gynecological applications.
Arthrex, Inc. holds 2.1% share, contributing through specialty orthopedic and sports medicine ablation solutions.
STARmed America holds 1.2% share, specializing in microwave and radiofrequency ablation technologies for tumor treatment.
Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=radiofrequency-ablation-devices-market?sai-v
Market Drivers
- Rising prevalence of chronic pain, cardiac arrhythmias, cancerous tumors, and other conditions treated with radiofrequency ablation (RFA).
- Growing preference for minimally invasive procedures due to reduced recovery time and lower complication risks.
- Advancements in radiofrequency ablation technology, including enhanced precision and real-time imaging guidance.
- Increasing number of outpatient surgical centers and rising patient awareness of RFA treatment options.
- Expansion of healthcare infrastructure and rising healthcare expenditure globally.
Industry Developments
- Launch of next-generation RFA devices with improved energy delivery and safety features.
- Strategic collaborations and partnerships between medical device manufacturers and healthcare institutions to expand clinical adoption.
- Expansion of product portfolios supporting a wider range of indications such as pain management, cardiac, and oncology.
- Growth in training programs and educational initiatives for clinicians on advanced RFA techniques.
- Integration of imaging modalities (e.g., ultrasound, CT) with RFA systems for enhanced procedural accuracy.
Regional Insights
North America - 38% share: "Driven by high prevalence of target conditions, strong adoption of minimally invasive therapies, advanced healthcare infrastructure, and robust reimbursement frameworks."
Europe - 27% share: "Supported by well-established healthcare systems, increasing clinical adoption of RFA procedures, and ongoing technological innovations."
Asia Pacific - 25% share: "Fueled by expanding healthcare access, rising awareness of minimally invasive treatments, and increasing investments in medical technology."
Latin America - 6% share: "Driven by improving healthcare infrastructure, growing minimally invasive surgery adoption, and awareness of advanced treatment options."
Middle East & Africa - 4% share: "Supported by gradual healthcare modernization, increasing clinical capabilities, and rising demand for advanced therapeutic technologies."
Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/radiofrequency-ablation-devices-market?sai-v
Key Segments
By Component Type
Generators dominate the component segment, driven by their central role in controlling energy delivery and treatment parameters. Ablation probes and needles account for a significant share, supported by frequent replacement and procedure-specific requirements. Accessories, including grounding pads and cables, contribute steadily by supporting safe and effective radiofrequency ablation procedures.
By Application
Oncology represents the largest application segment, driven by increasing use of radiofrequency ablation in minimally invasive cancer treatments. Pain management holds a substantial share, supported by adoption in chronic back pain and nerve-related conditions. Cardiology accounts for a notable portion, driven by use in treating cardiac arrhythmias. Other applications contribute to market growth through expanding clinical use in gynecology, urology, and cosmetic procedures.
By End User
Hospitals dominate the end-user segment, supported by advanced infrastructure and high procedural volumes. Ambulatory surgical centers represent a growing segment, driven by shift toward outpatient and minimally invasive procedures. Specialty clinics contribute steadily, supported by increased adoption of targeted ablation therapies.
Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription
Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.
✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring
Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Radiofrequency Ablation Devices Market to Reach US$ 13.54 Billion by 2033 at 10.7% CAGR; North America Leads with 38% Share here
News-ID: 4343830 • Views: …
More Releases from DataM intelligence 4 Market Research LLP
Mobile Threat Defense (MTD) Market to Reach US$ 10.5 Billion by 2030, Growing at …
According to DataM Intelligence, the global Mobile Threat Defense (MTD) market reached US$ 2.2 billion in 2022 and is expected to reach US$ 10.5 billion by 2030, growing at a CAGR of 22.0% during the forecast period 2024-2031. This growth is propelled by the rapid surge in mobile malware, phishing, and ransomware attacks targeting enterprises, increasing adoption of BYOD and remote work policies, strong demand for cloud-based MTD solutions, rising…
Digital Identity Solutions Market to Reach US$ 189.92 Billion by 2033 at 20.45% …
The Global Digital Identity Solutions Market reached US$ 35.50 billion in 2023 and increased to US$ 42.45 billion in 2024, and is expected to reach US$ 189.92 billion by 2033, growing at a CAGR of 20.45% during the forecast period 2025-2033. Market growth is driven by the rising need for secure identity verification, increasing digitalization across industries, and growing concerns over identity fraud and data security.
Digital identity solutions enable the…
Smart hospitals market is set for steady growth to US$ 230.94 billion by 2033 at …
The global smart hospitals market size reached US$ 58.82 billion in 2024 is expected to reach US$ 230.94 billion by 2033, growing at a CAGR of 16.5% during the forecast period 2025-2033. In recent years, hospitals have increasingly recognized that clinical excellence alone is no longer sufficient to ensure patient loyalty and trust experience, engagement, and personalization have become equally critical to healthcare delivery. This shift toward patient-centric care is…
Barrier Resins Market Set for Steady Growth to USD 32.12 Billion by 2032, Led by …
The Barrier Resins Market reached USD 20.32 billion in 2024 and is expected to reach USD 32.12 billion by 2032, growing at a CAGR of 5.89% during the forecast period 2025-2032.
Market growth is driven by rising demand for high-performance packaging in food and beverages, pharmaceuticals, and consumer goods to extend shelf life and prevent spoilage. Increasing adoption of sustainable, lightweight barrier films, stringent food safety regulations, and expansion in e-commerce…
More Releases for RFA
Radiofrequency Ablation (RFA) Devices Market Business Scenario Analysis By Globa …
The global Radiofrequency Ablation (RFA) devices market size was USD 4.30 Billion in 2022 and is expected to register a rapid revenue CAGR of 12.0% during the forecast period. The global market for Radiofrequency Ablation (RFA) devices is experiencing remarkable growth, driven by increasing demand for minimally invasive medical procedures and technological advancements. RFA devices are increasingly being adopted for treating cardiovascular diseases (CVDs), cancer, and pain management, positioning the…
High-carbon Ferrochromium Market 2023 | Futuristic Technology- NIPPON DENKO, Mar …
The High-carbon Ferrochromium report compiles the market information depending upon market development and growth factors, optimizing the growth path. In addition, it highlights the strategies and market share of the leading vendors in the particular market. The report follows a robust research methodology model that helps to make informed decisions. It obtains both qualitative and quantitative market information supported by primary research.
The High-carbon Ferrochromium research report recognizes and gets fundamental…
Endoscope - Radiofrequency Ablation (RFA) Market 2023 Size, Share, Industry, For …
The Endoscope - Radiofrequency Ablation (RFA) Market 2023 Report makes available the current and forthcoming technical and financial details of the industry. It is one of the most comprehensive and important additions to the Prudent Markets archive of market research studies. It offers detailed research and analysis of key aspects of the global Endoscope - Radiofrequency Ablation (RFA) market. This report explores all the key factors affecting the growth of…
Endoscope + Radiofrequency Ablation (RFA) Market Expected to Reach $7,471 Millio …
Endoscope + radiofrequency ablation (RFA) market was valued at $3,567 million in 2017 and is projected to reach $7,471 million by 2025, growing at a CAGR of 9.6% from 2018 to 2025. North America was the highest revenue contributor in 2017 and is expected to maintain this trend throughout the forecast period.
Radiofrequency ablation (RFA) utilizes thermal energy to accomplish targeted tissue destruction. RFA was initially studied for the treatment of…
Endoscope + Radiofrequency Ablation (RFA) Market 2022 | Detailed Report- Boston …
The Endoscope + Radiofrequency Ablation (RFA) report understands the current and future competitive scenario across types, countries, and applications.It provides accurate, up-to-date analysis of markets and companies.The report use reliable information and analysis to gain a deeper understanding of the current factors impacting the industry.
The Endoscope + Radiofrequency Ablation (RFA) report provides exact and accurate data that helps companies of all sizes to make timely decisions. Furthermore, the report provides…
Endoscope + Radiofrequency Ablation (RFA) Market Emerging Trends in COVID-19 Out …
Allied Market Research published a new report, titled, "Endoscope + Radiofrequency Ablation (RFA)” The report offers an extensive analysis of key growth strategies, drivers, opportunities, key segment, Porter’s Five Forces analysis, and competitive landscape. This study is a helpful source of information for market players, investors, VPs, stakeholders, and new entrants to gain thorough understanding of the industry and determine steps to be taken to gain competitive advantage.
Covid-19 Impact on…
